NCT03337113

Brief Summary

Smoking remains the leading cause of preventable death in the United States, and current first-line treatments leave the majority of tobacco dependent individuals unable to quit. The inability to quit despite motivation to do so, is thought to result in part, from self-control failure. Working memory (WM) deficits contribute to imbalanced self-control and allow automatic impulses to drive behavior. Thus, WM plays a critical role in addictive behavior, and is particularly relevant to smoking. Indeed, a strong link between WM and smoking has been established in the literature; most notably, degree of WM impairment and deficits in activation in associated brain regions predict time to relapse, and WM moderates the relationship between craving and relapse. Given these insights, researchers have been examining interventions that may target WM including WM training (WMT) and repetitive Transcranial Magnetic Stimulation (rTMS). WMT involves taxing this executive function repeatedly over time and has shown positive preliminary results in improving measures of self-control and reducing consumption of addictive substances. Similarly, rTMS, a non-invasive brain stimulation procedure that stimulates neuronal tissues and increases cortical excitability, has been shown to increase WM capacity and reduce craving and consumption of several addictive substances including nicotine. While these interventions have demonstrated initial promise in affecting addictive behaviors, the magnitude and durability of their effects may be limited. Recently, researchers have posited - but not yet empirically tested - that WMT administered in combination with rTMS may result in an additive or supra-additive effect in treating addictive processes. This is highly significant; the clinical utility of rTMS over current first line treatments may be limited if factors with potential to enhance its effectiveness are not examined. Given these recent advances in the literature, the primary objective of the proposed study is to evaluate the individual and combined effects of Working Memory (WM) training and repetitive Transcranial Magnetic Stimulation (rTMS) on WM performance and smoking behaviors as well as critical mediators of these effects. These aims will be examined in a sample of tobacco dependent adults (N=130) utilizing a 2x2 factorial experimental design including four groups (WMT+rTMS, sham WMT+rTMS, WMT+sham TMS, and sham WMT+sham rTMS) capable of isolating independent and combined effects of WMT and rTMS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Mar 2018

Typical duration for phase_2

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 8, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

March 5, 2018

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2021

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

May 2, 2022

Completed
Last Updated

May 2, 2022

Status Verified

April 1, 2022

Enrollment Period

2.9 years

First QC Date

October 25, 2017

Results QC Date

January 24, 2022

Last Update Submit

April 29, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • Time to Lapse on a Smoking Lapse Analogue Task

    The Delay to Smoking Analogue Task is a behavioral choice paradigm that is sensitive to smoking medication effects in which participants earn monetary rewards for delaying initiation of cigarette smoking in 5-minute increments over a 50-minute period, following 3-hours of observed smoking deprivation. Range = 0 - 50 minutes. Higher scores indicate better ability to delay smoking.

    an average of 30 days after baseline

  • Working Memory Performance 1

    NIH Examiner N-back score. The minimum value is 0 and maximum is 90, higher scores indicate a better outcome. Calculated change scores are presented (outcome score at day 30 minus baseline score).

    Change from baseline score to score at 30 days

  • Working Memory Performance 2

    NIH Examiner Dot Counting Task score. The minimum total score is 0 and the maximum score is 27, higher scores indicate a better outcome. Calculated change scores are presented (outcome score at day 30 minus baseline score).

    Change from baseline score to score at 30 days

  • Working Memory Performance 3

    Mean End Level Score on Maastricht University Working Memory Tasks. For each scale (i.e. visuospatial, back-digit, and letter-sequencing) the minimum total is 3 and the maximum is 15, higher scores indicate a better outcome.

    Change from baseline score to score at 30 days

  • Cigarette Consumption

    Self reported number of cigarettes smoked daily

    throughout 60 day study participation, cigarettes per day assessed at outcome reported

Secondary Outcomes (2)

  • Delay Discounting

    Change from baseline score to score at 30 days

  • Cigarette Demand

    Change from baseline score to score at 30 days

Study Arms (4)

WMT + rTMS

EXPERIMENTAL

WMT + rTMS is the Working Memory Training + repetitive Transcranial Magnetic Stimulation arm. Both conditions are active.

Other: Working Memory TrainingDevice: repetitive Transcranial Magnetic Stimulation

Sham WMT + rTMS

ACTIVE COMPARATOR

Sham WMT + rTMS is the sham Working Memory Training + repetitive Transcranial Magnetic Stimulation arm. This condition isolates the effects of rTMS. WMT is inactive.

Other: Sham Working Memory TrainingDevice: repetitive Transcranial Magnetic Stimulation

WMT + sham rTMS

ACTIVE COMPARATOR

WMT + sham rTMS is the Working Memory Training + sham repetitive Transcranial Magnetic Stimulation arm. This condition isolates the effects of WMT. rTMS is inactive.

Other: Working Memory TrainingDevice: Sham repetitive Transcranial Magnetic Stimulation

Sham WMT + sham rTMS

SHAM COMPARATOR

sham WMT + sham rTMS is the sham Working Memory Training + sham repetitive Transcranial Magnetic Stimulation arm. Both are inactive in this arm.

Other: Sham Working Memory TrainingDevice: Sham repetitive Transcranial Magnetic Stimulation

Interventions

The Working Memory Training condition: This condition will include 30 sessions across 4 weeks (10 remote sessions prior to initiation of the rTMS stimulation, and 20 lab sessions on rTMS stimulation days). Participants will complete three distinct WM tasks in each session: a visuospatial WM task, a backward digit span task, and a letter span task. In the training condition, the difficulty level of all three WM tasks will be automatically adjusted on a trial-by-trial basis. An identical protocol and software have demonstrated efficacy in increasing WM capacity, and this improvement in WM predicts reduction in addictive behavior.

Also known as: Executive Function Training
WMT + rTMSWMT + sham rTMS

In the Sham WMT condition, the difficulty level of the WM tasks will not be adjusted; instead it will remain at the initial easy level throughout each task (i.e., three items in each sequence). All other aspects of the condition are identical to the active WMT condition.

Also known as: Sham Executive Function Training
Sham WMT + rTMSSham WMT + sham rTMS

The rTMS Condition: rTMS will be delivered with a Magstim Rapid2 system using Magstim Air Film Coils. rTMS pulses will be delivered at 10 Hz (100% resting motor threshold, RMT) in 40, 5 second trains, with 15 second inter-train interval, for a total of 2000 pulses per session. Active or sham rTMS will be applied over the left DLPFC; corresponding with the standard "F3" location on scalp (F3=left frontal lobe, location #3 for electrode placement using international 10-20 system for scalp measurements). Five consecutive daily sessions will occur on two consecutive weeks, for a total of 10 sessions. RMT, defined as the amount of energy required to induce movement in the contralateral abducer pollicis brevis in at least 50% of stimulations, will be assessed on first day of application.

Also known as: Neuromodulation
Sham WMT + rTMSWMT + rTMS

Sham rTMS will be identical to active treatment, with the exception that mu-metal plates attached to the sham coil block the magnetic field while providing a sensation of stimulation.

Also known as: Sham Neuromodulation
Sham WMT + sham rTMSWMT + sham rTMS

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • meet safety guidelines for application of rTMS
  • be 18-60 years of age
  • have smoked cigarettes regularly for at least one year
  • currently smoke at least 10 cigarettes per day
  • have a carbon monoxide (CO) level \>10 ppm
  • currently use no other nicotine products regularly

You may not qualify if:

  • meet criteria for current alcohol or substance dependence
  • have a current affective disorder (depression, dysthymia, or mania) or psychotic symptoms
  • are currently pregnant or lactating, or intend to become pregnant
  • have a health condition for which rTMS is contraindicated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Brown University

Providence, Rhode Island, 02906, United States

Location

Butler Hospital

Providence, Rhode Island, 02906, United States

Location

Related Publications (1)

  • Lechner WV, Philip NS, Kahler CW, Houben K, Tirrell E, Carpenter LL. Combined Working Memory Training and Transcranial Magnetic Stimulation Demonstrates Low Feasibility and Potentially Worse Outcomes on Delay to Smoking and Cognitive Tasks: A Randomized 2 x 2 Factorial Design Pilot and Feasibility Study. Nicotine Tob Res. 2022 Nov 12;24(12):1871-1880. doi: 10.1093/ntr/ntac183.

MeSH Terms

Conditions

Tobacco Use Disorder

Interventions

Transcranial Magnetic StimulationTranscutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeuticsElectric Stimulation TherapyPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Results Point of Contact

Title
William Lechner
Organization
Kent State University

Study Officials

  • William V Lechner, Ph.D.

    Kent State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
The participant will be prevented from having knowledge of the interventions assigned.
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: A 2x2 factorial model will include four groups (Working Memory Training \[WMT\] + repetitive Transcranial Magnetic Stimulation \]rTMS\], sham WMT+rTMS, WMT+sham TMS, and sham WMT+sham rTMS) capable of isolating independent and combined effects of WMT and rTMS on the primary outcome variables.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 25, 2017

First Posted

November 8, 2017

Study Start

March 5, 2018

Primary Completion

January 31, 2021

Study Completion

January 31, 2021

Last Updated

May 2, 2022

Results First Posted

May 2, 2022

Record last verified: 2022-04

Locations